Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
ZR-75-1
HR+
Luminal
PD 98059
MEK
MAPK
12003.159
uM
inf
inf
0.4060 0.4060 0.0000 0.2531
0.490
1.2466
ZR-75-1
HR+
Luminal
PD173074
FGFR1/3
RTK
10444.093
uM
10.05660
19.1860
-0.4476 -1.0000 1.7008 0.2437
0.8956
1.0902
ZR-75-1
HR+
Luminal
PD173074
FGFR1/3
RTK
7553.093
uM
15.65140
35.63880
0.0366 -1.0000 1.3351 0.1487
0.9188
1.1429
ZR-75-1
HR+
Luminal
PD184352
MEK
MAPK
11660.146
uM
583.9090
1000.00000
0.4704 -0.0361 0.1295 0.2471
0.6207
0.9684
ZR-75-1
HR+
Luminal
PD184352
MEK
MAPK
11660.146
uM
583.9090
1000.00000
0.4704 -0.0361 0.1295 0.2471
0.6207
0.9684
ZR-75-1
HR+
Luminal
PD184352
MEK
MAPK
12003.155
uM
inf
0.00501
0.8304 0.8464 0.5638 0.1047
0.6326
1.1249
ZR-75-1
HR+
Luminal
PD184352
MEK
MAPK
12003.155
uM
inf
0.00501
0.8304 0.8464 0.5638 0.1047
0.6326
1.1249
ZR-75-1
HR+
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7552.095
uM
283.16160
264.75520
0.1397 0.1427 5.0000 0.2204
0.9126
1.1106
ZR-75-1
HR+
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7553.095
uM
0.22608
0.08707
0.3980 0.4452 2.3166 0.4525
0.9707
1.1473
ZR-75-1
HR+
Luminal
PS-1145
IKK
NFKB
7553.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0337
-2.7068
1.0305
ZR-75-1
HR+
Luminal
PS-1145
IKK
NFKB
7552.065
uM
inf
inf
0.9528 0.9528 0.0000 0.0308
0.1104
1.1323
ZR-75-1
HR+
Luminal
Purvalanol A
CDK1
CDK
7553.067
uM
inf
198.88240
0.8686 0.5659 4.7905 -0.0009
0.6110
1.1302
ZR-75-1
HR+
Luminal
Purvalanol A
CDK1
CDK
7552.067
uM
29.95480
15.47670
0.4611 0.4816 5.0000 0.1146
0.9648
1.0224
ZR-75-1
HR+
Luminal
QNZ
NFkB
NFKB
7553.096
uM
0.05947
0.02437
0.2664 0.3269 1.1891 0.3945
0.9421
1.1407
ZR-75-1
HR+
Luminal
Ribavirin
15346.211
uM
inf
inf
0.7643 0.7643 0.0000 0.0402
-0.0208
0.6395
ZR-75-1
HR+
Luminal
SB-3CT
MMP2/9
MMP
12003.168
uM
inf
inf
0.7827 0.7827 0.0000 0.1268
-0.0117
1.1370
ZR-75-1
HR+
Luminal
SB-3CT
MMP2/9
MMP
11660.144
uM
119.48650
98.97520
0.5398 0.0841 0.9775 0.0781
0.8604
1.0279
ZR-75-1
HR+
Luminal
Selumetinib
MEK
MAPK
12003.155
uM
inf
inf
0.7852 0.7852 0.0000 0.1164
0.5363
1.1249
ZR-75-1
HR+
Luminal
Selumetinib
MEK
MAPK
11660.146
uM
5.02770
999.65480
0.2909 -0.7800 0.1776 0.3153
0.9108
0.9684
ZR-75-1
HR+
Luminal
Sigma A6730
AKT
AKT
11660.153
uM
1.41070
17.97910
-0.2748 -1.0000 0.4317 0.4000
0.9343
0.8197
ZR-75-1
HR+
Luminal
Sigma A6730
AKT
AKT
12003.165
uM
0.26905
1.07040
-0.7554 -0.7752 0.6780 0.5948
0.9734
1.0267
ZR-75-1
HR+
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7552.084
uM
19.66180
64.79560
-0.8315 -0.9096 0.8691 0.4079
0.9641
1.1307
ZR-75-1
HR+
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7553.085
uM
68.44260
82.31120
-0.7562 -0.7579 5.0000 0.1326
0.9958
1.1198
ZR-75-1
HR+
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7552.067
uM
10.03460
12.54540
-0.9796 -0.9797 4.8587 0.3735
0.9983
1.0224
ZR-75-1
HR+
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7553.067
uM
11.63830
14.79810
-0.9723 -0.9723 4.4963 0.3638
0.9990
1.1302